Home Tags Drugs and Pharmaceuticals

Tag: Drugs and Pharmaceuticals

Boothwyn Pharmacy in Kennett Square Now Manufacturing Hand Sanitizer

KENNETT SQUARE, Pa., March 26, 2020 (SEND2PRESS NEWSWIRE) -- Boothwyn Pharmacy, a PCAB-accredited compounding pharmacy located mere minutes from the heart of Kennett Square, Pennsylvania, has dedicated resources to manufacture hand sanitizer.

iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society of Hematology Annual Meeting

STONY BROOK, N.Y., Nov. 14, 2019 (SEND@PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.

C Diff Foundation Raises Clostridioides difficile Awareness in St. Louis on Nov. 6-7 at 7th Annual International Conference and Health EXPO

ST. LOUIS, Mo., Oct. 14, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the 7th Annual International C. diff. Conference and Health EXPO is honored to welcome over 30 international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies. November 6 - 7, 2019 at the DoubleTree by Hilton Westport Hotel.

BioAdaptives, Inc. Announces Return to Fully Reporting and Appointment of President

LAS VEGAS, Nev., Sept. 11, 2019 (SEND2PRESS NEWSWIRE) -- BioAdaptives, Inc. (OTC BB: BDPT) announced the Company's return to a fully-reporting entity, and the appointment of Mr. Robert W. Ellis as its new President, reporting to Dr. Edward E. Jacobs, Jr.

2019 Lupus Insight Prize Awarded to Dr. Ignacio Sanz: Recognizes Studies of Harmful Immune Cells in Lupus

BOSTON, Mass., June 19, 2019 (SEND2PRESS NEWSWIRE) -- The Lupus Research Alliance has awarded its 2019 Lupus Insight Prize to Ignacio Sanz, MD, for discovering that certain little-understood immune system cells are a major source of the harmful proteins that promote lupus symptoms. His work could spark new treatments for the disease and help doctors determine which patients could benefit from current drugs.
The C. Diff Foundation

C Diff Foundation Recognizes Rebiotix CEO Lee Jones with its 2019 ‘Above and Beyond’ Award

NEW PORT RICHEY, Fla. /Florida Newswire/ -- The C. Diff Foundation Board of Directors announced today that the 2019 "Above and Beyond" Award will be presented to Rebiotix CEO Lee Jones in Roseville, Minnesota. The award, given to one recipient annually, is given to a person or organization that show extraordinary dedication to C. diff patient safety, advocacy, and overall drive to improve the lives of those impacted by the infection.

Pet King Brands Celebrates 20 Years as a Leader in the Pet Health Products Industry

WESTMONT, Ill., Jan. 15, 2019 (SEND2PRESS NEWSWIRE) -- Pet health products company, Pet King Brands, Inc. - the maker of veterinarian-recommended brands ZYMOX(R) Dermatology and Oratene(R) Brushless Oral Care - celebrates 20 years of helping pets find relief from problematic ear, skin and mouth conditions.

Leading Companies to Support C Diff Foundation 6th Annual International C.diff. Conference and Health EXPO, Nov. 8-9, Philadelphia

PHILADELPHIA, Pa., Oct. 31, 2018 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation is honored to welcome leading companies to the 6th Annual International "C.diff. Awareness Conference and Health EXPO," as they come together to make a global difference. These companies are dedicated to the prevention, diagnostics, treatments, environmental safety products and services focused on C.difficile infections and Healthcare-associated infections and whose role serves great importance in the C.diff. community.

Healthcare Tech Outlook Names Delta Care Rx a Top 10 Pharmacy Management Solution Provider

FREMONT, Calif., April 23, 2018 (SEND2PRESS NEWSWIRE) -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, has been named one of the "Top 10 Pharmacy Management Solution Providers of 2018," according to Healthcare Tech Outlook, a digital and print magazine publication of Valley Media, Inc.

Alejandro Arboleda Named 2018 Koch Kellan Scholar

PORTLAND, Ore., April 13, 2018 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching or research career in ophthalmology.
C Diff Foundation

C Diff Foundation Presents ‘Making a Difference’ Award to CutisPharma for Contribution to C. diff. Community

NEW PORT RICHEY, Fla. /Florida Newswire/ -- The C Diff Foundation announced today that it presented CutisPharma, Inc., its "Making a Difference" award as a special recognition of the significant contribution that CutisPharma has made to the C.diff. Community: helping the advancement of C.diff. awareness as well as expanding treatment options for C.diff. patients.

Delta Care Rx Now Integrates with Suncoast Electronic Medical Records

PITTSBURGH, Pa., Feb. 16, 2018 (SEND2PRESS NEWSWIRE) -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces a robust integration with Suncoast by Complia Health, a leading global provider of home health care and hospice software solutions.

ScriptDrop and Albertsons Hurricane Relief Efforts To Be Covered on ‘The Success Files’ with Rob Lowe

COLUMBUS, Ohio, Nov. 2, 2017 (SEND2PRESS NEWSWIRE) -- ScriptDrop, a healthcare technology company providing medication reminders and deliveries while fighting prescription abandonment and abuse, today announced that it will be featured on "The Success Files" hosted by Rob Lowe, airing on MSNBC and PBS in 2018.

Paragon BioTeck Calls Emerging Leaders to Apply for 2018 Ophthalmology Scholarship

PORTLAND, Ore., Oct. 2, 2017 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.

Verify Smart Corp (VSMR) Signs Letter of Intent to Acquire Equity Stake and Exclusive International Reseller Rights in Med-Con Technologies, LLC

FERNLEY, Nev., June 8, 2017 (SEND2PRESS NEWSWIRE) -- Verify Smart Corporation (OTC:VSMR / OTCMKTS:VSMR) a Global innovator in financial fraud prevention and digital distribution solutions announced today that it has signed a Letter of Intent to acquire an equity stake and exclusive international reseller rights in Med-Con Technologies, LLC for cash and stock.

Medical Experts Unite Regarding Health Benefits of Testosterone Therapy in Women

IRVING, Texas, April 19, 2017 (SEND2PRESS NEWSWIRE) - BioTE(R) Medical announces a forum of medical experts gathering before the Age Management Medicine Group (AMMG) to form consensus on testosterone therapy in women. The AMMG conference runs April 27-30, 2017 in Orlando, Florida.

Delta Care Rx Announces Patrick White, MD, Inaugural Recipient of Delta Distinguished Scholar Award

PITTSBURGH, Pa., April 18, 2017 (SEND2PRESS NEWSWIRE) -- Delta Care Rx today announced the first-ever recipient of the Delta Distinguished Scholar award. Patrick White, MD, HMDC, FACP, FAAHPM, chief medical officer of BJC Hospice, St. Louis, and assistant professor of medicine at Washington University, has received an initial $25,000 research grant, with a $500,000 lifetime potential, for study into the comparative and cost effectiveness of pharmaceuticals.

Trump’s wrong attack on Opioid Epidemic

CORTE MADERA, Calif., March 31, 2017 (SEND2PRESS NEWSWIRE) -- Dr. Don Harte, chiropractic activist, says Trump's new panel, headed by Chris Christie, to deal with the opioid epidemic, is "philosophically and scientifically dead wrong." Dr. Harte declares, "The reason for this epidemic is clear. Orthopedists and other doctors freely prescribe Oxycontin, Fentanyl, Soma and other opioid drugs, get their patients addicted."

Ruling Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formula

PORTLAND, Ore., Nov. 21, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc. (Paragon), announces a monumental ruling handed down by the United States Patent and Trademark Office affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

eAgile Announces partnership with Heinlein Plastik to bring its eSeal RFID Solution to Europe

GRAND RAPIDS, Mich., and ZURICH, Switzerland, Sept. 29, 2016 (SEND2PRESS NEWSWIRE) -- eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announces a partnership with Heinlein Plastik-Technik GmbH to bring RFID smart packaging solutions to the European cap and closure marketplace. eSeal is the first turnkey solution engineered to integrate the benefits of RFID into the billions of caps and closures consumed by the over-the-counter pharmaceutical, nutraceutical, cosmetic and chemical manufacturers.